journal articles
CORRIGENDUM TO “LECANEMAB FOR TREATMENT OF INDIVIDUALS WITH EARLY ALZHEIMER’S DISEASE (AD) WHO ARE APOLIPOPROTEIN E Ε4 (APOE Ε4) NON-CARRIERS OR HETEROZYGOTES” [THE JOURNAL OF PREVENTION OF ALZHEIMER\'S DISEASE (2026) 100507]
Richard Perry, Christopher Kipps, Maria Eugenia Soto Martín, Marco Bozzali, Giancarlo Logroscino, Sarah Trafford, Shobha Dhadda, Michio Kanekiyo, Amanda Goodwin, Mark Hodgkinson, Steven Hersch, Michael Irizarry, Lynn Kramer, Lutz Froelich
CITATION:
Richard Perry ; Christopher Kipps ; Maria Eugenia Soto Martín ; Marco Bozzali ; Giancarlo Logroscino ; Sarah Trafford ; Shobha Dhadda ; Michio Kanekiyo ; Amanda Goodwin ; Mark Hodgkinson ; Steven Hersch ; Michael Irizarry ; Lynn Kramer ; Lutz Froelich (2026): Corrigendum to “Lecanemab for treatment of individuals with early Alzheimer’s Disease (AD) who are apolipoprotein E ε4 (ApoE ε4) non-carriers or heterozygotes” [The Journal of Prevention of Alzheimer's Disease (2026) 100507]. The Journal of Prevention of Alzheimer’s Disease (JPAD). https://doi.org/10.1016/j.tjpad.2026.100527